Diametric Capital »

Lineage Cell Therapeutics In shares owned by Diametric Capital

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Diametric Capital

Quarter filed Position value Share count Share price at filing
2023-03-31 $76k 51k 1.50
2021-03-31 $63k 27k 2.36
2020-06-30 $21k 24k 0.89